A mouse PDX clinical trial reveals broad efficacy of niraparib and vc-seco-DUBA anti-HER2 ADC SYD985 in HER2/neu expressing endometrial cancer

BIOMEDICINE & PHARMACOTHERAPY · Published 2026-08-04 · DOI 10.1016/j.biopha.2026.119830

Free full text

Authors (14)

Cristian Pablo Moiola, Carlos Lopez-Gil, Marta Rebull, Ana Sotoca, Irene De la Calle, Ángel García, Melek Denizli, Lourdes Salazar, Monique van der Vleuten, Vicente Bebia, Valeria Tubita, Patrick Groothuis, Antonio Gil-Moreno, Eva Colas

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Moiola, C., Lopez-Gil, C., Rebull, M., et al. (2026). A mouse PDX clinical trial reveals broad efficacy of niraparib and vc-seco-DUBA anti-HER2 ADC SYD985 in HER2/neu expressing endometrial cancer. BIOMEDICINE & PHARMACOTHERAPY. https://doi.org/10.1016/j.biopha.2026.119830

Related articles

• Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer · Genome Medicine · 2022 · Cites or is cited by this article
• 2-deoxy-d-ribose: A multifaceted player at the crossroads of cancer metabolism · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Activity-dependent metabolic vulnerability in the APPPS1 Alzheimer’s disease mouse model during isoflurane anesthesia · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Tailoring pH-responsive charge-conversional interfaces in ionizable lipid-based nanoliposomes for synchronized co-delivery and synergistic therapy of triple-negative breast cancer · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Preserved motor function and prolonged sensory local anesthesia with novel PLGA microparticles co-encapsulating lidocaine and capsaicin · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Iron–quercetin complex induces ex vivo proteomic remodeling in circulating proangiogenic cells derived from human peripheral blood mononuclear cells · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Acetonic extract of Saskatoon berry attenuates amyloid-associated neurotoxicity in cellular and Drosophila melanogaster Alzheimer’s disease models · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Design of sunflower trypsin inhibitor 1 derived probes targeting the LDLR and evaluation of their brain delivery · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• The chalcone derivative DN-053 attenuates renal fibrosis and inhibits p38 MAPK and STAT3 signaling in renal fibroblasts · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Urinary biomarkers in muscle-invasive bladder cancer: Current state and open opportunities for neoadjuvant chemotherapy response prediction and patient stratification · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal